← All trials
NCT03440359
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2012
- Primary completion
- Nov 2, 2016
- Completion date
- Dec 30, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Eastern Virginia Medical SchoolLead sponsor
- Eastern Virginia Medical SchoolReponsible party - principal investigator
- Eastern Virginia Medical SchoolOverall official - principal investigator
- Watson PharmaceuticalsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.